HENDERA
831152
Hengerda New Materials
300946
Fujian Nebula Electronics.,Ltd
300648
4
Cubic Digital Technology
300344
5
HNAC Technology
300490
US Stock MarketDetailed Quotes
OACCU Oaktree Acquisition Corp. III Life Sciences
- 10.170
- 0.0000.00%
Close Feb 13 13:17 ET
286.03MMarket Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open10.170Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)28.13MShares10.22052wk High0.00P/B228.83MFloat Cap9.99052wk Low--Dividend TTM22.50MShs Float10.220Historical High--Div YieldTTM0.00%Amplitude9.990Historical Low--Avg Price1Lot Size
About Oaktree Acquisition Corp. III Life Sciences Company
Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.
Company Profile
SymbolOACCU
Company NameOaktree Acquisition Corp. III Life Sciences
Listing DateOct 24, 2024
Issue Price10.00
Founded1995
CEOMr. Zaid Pardesi
MarketNASDAQ
Employees3
Fiscal Year Ends12-31
Address333 South Grand Avenue,28th floor
CityLos Angeles
ProvinceCalifornia
CountryUnited States of America
Zip Code90071
Phone1-213-830-6300
Company Executives
- Name
- Position
- Salary
- Zaid Pardesi
- Chief Executive Officer and Director
- --
- Courtney Conigliaro
- Chief Financial Officer
- --
- Mathew M. Pendo
- Chief Operation Officer
- --
- Dr. Aman Kumar, M.D.
- Chairman of the Board
- --
- Paul M. Meister
- Independent Director
- --
- Dr. Alvin Shih, M.D.
- Independent Director
- --
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025